Leukemia and lymphoma are cancers that affect the blood or bone marrow. Fifteen percent of people with leukemia have chronic myeloid leukemia (CML), which has seen a 55% jump in new cases over the ...

Chronic myeloid leukemia may seem to appear suddenly, but new research shows it begins years before diagnosis with an explosive surge of growth. Scientists tracked how a single genetic accident—the ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor (TKI) treatment for patients with chronic-phase chronic myeloid leukemia ...

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients. In your work with caregivers, how have you seen them ...

Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies ...

Federally funded science is critical to discovering new treatments for disease. Just ask Melvin Mann, who was a 37-year-old Army major when doctors diagnosed him with an aggressive and deadly blood ...

Imatinib marked a paradigm shift in CML treatment, offering significant improvements over previous therapies and reducing adverse effects. Despite imatinib's success, resistance and the need for ...

Co announces that positive clinical results supporting the development of Ceflatonin in patients with chronic myeloid leukemia, including patients who had failed treatment with Gleevec, have been ...